Callan Capital’s Incyte INCY Stock Holding History

Callan Capital’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,929	Closed	-$202K	–	382
2024 Q4	$202K	Sell	2,929 -200	-6%	-$14.3K	0.01%	323
2024 Q3	$207K	Buy	+3,129	New	+$200K	0.01%	328

Other funds holding INCY

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Callan Capital's INCY Position: Q1 2025 in Review

Callan Capital sold out of Incyte (INCY) in Q1 2025, closing a stake of 2,929 shares — an estimated $202K sold.

Callan Capital first reported a position in INCY in Q3 2024 and held it in 2 quarters. The position peaked at $207K in Q3 2024. 630 funds tracked by Wall St. Rank hold INCY as of Q1 2025.

Callan Capital reported no remaining Incyte position as of Q1 2025 after selling out during the quarter.
Callan Capital sold 2,929 Incyte shares in Q1 2025, an estimated $202K.
Callan Capital first reported a position in Incyte in Q3 2024 and held it in 2 quarters.
Callan Capital's Incyte position peaked at $207K in Q3 2024.
630 funds tracked by Wall St. Rank held Incyte as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.